FeesSafety
Pluang+

Nintendo Switch 2 sales drop 41% in Q2 after price hikes amid rising memory costs

Market News
05 Nov 2026, 08:56 WIB
CNBC
View Source
Bearish
Nintendo Switch 2 sales drop 41% in Q2 after price hikes amid rising memory costs

Nintendo's Switch 2 sales fell sharply by 41% in the fiscal second quarter, with only 2.67 million units sold compared to the previous year. The decline follows price increases implemented in the U.S., Canada, and Japan due to rising memory costs. Sales also dropped from 3.82 million units in the prior quarter. This sales slump highlights the impact of higher prices on consumer demand for Nintendo's flagship gaming device.

Nintendo Switch 2 sales are the subject, with a sharp 41% drop reported. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Nov 05, 2026 14:11 WIB: Among 134 US stocks, 85 rose and 41 fell. Notable movers include Abercrombie & Fitch Co. (ANF) at USD 171.25 with +8.72%, Under Armour Inc Class A (UA) at USD 5.56 with +8.17%, and Macy's Inc (M) at USD 25.70 with +7.62%.

More News

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics raises $133M to advance novel TCR bispecific therapies for cancer and autoimmune diseases

T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...

Company Fundamentals
Bullish
14 minutes ago
UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

UBS Group AG's stake in Bang & Olufsen drops below 5% after previously exceeding it.

UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...

Neutral
14 minutes ago
Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers spins off diagnostics unit as Olyrian Diagnostics, aiming for standalone status by 2028

Siemens Healthineers has begun separating its in vitro diagnostics business into a standalone company named Olyrian Diagnostics, expected to complete by mid-2028. This move aims to give the diagnostics unit a distinct market presence while continuing...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers' order backlog grows 52% in 2026 Q3; reaffirms full-year guidance.

IQM Quantum Computers reported a 52% increase in order backlog to €102.5 million by September 30, 2026, driven by major new contracts including the LUMI-IQ Halocene order. Q3 revenue rose 51% year-over-year to €8.9 million, with cash reserves at €260...

Company Fundamentals
Bullish
1 hour ago
IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers boosts order backlog 52% in 2026, reaffirms full-year revenue guidance.

IQM Quantum Computers reported a 52% increase in order backlog to EUR 102.5 million by September 2026, driven by strong new orders including a EUR 33 million contract for its error-correction platform. Q3 revenue rose 51% year-over-year to EUR 8.9 mi...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App